These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2791348)

  • 1. Kinetics of isotype-specific humoral immunity in rubella vaccine-associated arthropathy.
    Tingle AJ; Pot KH; Yong FP; Puterman ML; Hancock EJ
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S99-106. PubMed ID: 2791348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on vaccine-induced rubella arthritis. Serologic findings before and after immunization.
    Tingle AJ; Kettyls GD; Ford DK
    Arthritis Rheum; 1979 Apr; 22(4):400-2. PubMed ID: 426884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective immunological assessment of arthritis induced by rubella vaccine.
    Tingle AJ; Yang T; Allen M; Kettyls GD; Larke RP; Schulzer M
    Infect Immun; 1983 Apr; 40(1):22-8. PubMed ID: 6339401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.
    Mitchell LA; Zhang T; Ho M; Décarie D; Tingle AJ; Zrein M; Lacroix M
    J Clin Microbiol; 1992 Jul; 30(7):1841-7. PubMed ID: 1629342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific immunoglobulin responses in serum and nasal secretions after the administration of attenuated rubella vaccine.
    Cradock-Watson JE; Macdonald H; Ridehalgh MK; Bourne MS; Vandervelde EM
    J Hyg (Lond); 1974 Aug; 73(1):127-41. PubMed ID: 4608331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of immunoglobulin G and A antibodies to rubella virus in urine and antibody responses to vaccine-induced infection.
    Takahashi S; Machikawa F; Noda A; Oda T; Tachikawa T
    Clin Diagn Lab Immunol; 1998 Jan; 5(1):24-7. PubMed ID: 9455874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rubella virus vaccine associated arthropathy in postpartum immunized women: influence of preimmunization serologic status on development of joint manifestations.
    Mitchell LA; Tingle AJ; Grace M; Middleton P; Chalmers AC
    J Rheumatol; 2000 Feb; 27(2):418-23. PubMed ID: 10685808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of chronic arthropathy among women after rubella vaccination. Vaccine Safety Datalink Team.
    Ray P; Black S; Shinefield H; Dillon A; Schwalbe J; Holmes S; Hadler S; Chen R; Cochi S; Wassilak S
    JAMA; 1997 Aug; 278(7):551-6. PubMed ID: 9268275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity and sub-class distribution of IgG-class antibodies following vaccination with a live rubella virus vaccine.
    Lehtinen M
    Vaccine; 1987 Jun; 5(2):88-9. PubMed ID: 3604396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunoglobulin M response to rubella vaccine in young adult women.
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
    J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal and postnatal production of IgM and IgA antibodies to rubella virus studied by antibody capture immunoassay.
    Grangeot-Keros L; Pillot J; Daffos F; Forestier F
    J Infect Dis; 1988 Jul; 158(1):138-43. PubMed ID: 3392411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antibody responses to rubella virus infection in males and females.
    Mitchell LA; Zhang T; Tingle AJ
    J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation.
    Tingle AJ; Allen M; Petty RE; Kettyls GD; Chantler JK
    Ann Rheum Dis; 1986 Feb; 45(2):110-4. PubMed ID: 3947141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.